These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3161481)

  • 41. Restoration of post-thrombotic peripheral collateral circulation in the cat by ketanserin, a selective 5-HT2-receptor antagonist.
    Nevelsteen A; De Clerck F; Loots W; De Gryse A
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):268-79. PubMed ID: 6486973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Demonstration of alpha-adrenoceptor antagonism by the 5HT2 antagonist, ketanserin (R49945), in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Spence CD; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1984; 11(6):597-604. PubMed ID: 6152610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans.
    Matzen S; Secher NH; Knigge U; Pawelczyk J; Perko G; Iversen H; Bach FW; Warberg J
    Acta Physiol Scand; 1993 Oct; 149(2):163-76. PubMed ID: 8266806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of a selective 5-HT2 antagonist, ketanserin, on the pulmonary responses to Escherichia coli endotoxin.
    Ball HA; Parratt JR; Rodger IW
    Br J Pharmacol; 1983 Oct; 80(2):295-301. PubMed ID: 6360280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study.
    Demoulin JC; Bertholet M; Soumagne D; David JL; Kulbertus HE
    Lancet; 1981 May; 1(8231):1186-8. PubMed ID: 6112531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity.
    Ramage AG
    Eur J Pharmacol; 1985 Jul; 113(3):295-303. PubMed ID: 2931285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular activity of ketanserin (R 41 468), a selective 5-HT2 receptor antagonist.
    Van Nueten JM; Xhonneux R; Vanhoutte PM; Janssen PA
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):328-9. PubMed ID: 7271395
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension.
    Ferrara LA; Fasano ML; Soro S; Rubba P; Iannuzzi A
    J Clin Pharmacol; 1985 Apr; 25(3):187-92. PubMed ID: 3158674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular toxicity of palytoxin in anesthetized dogs.
    Ito K; Urakawa N; Koike H
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):146-54. PubMed ID: 6127986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of ketanserin on phenylephrine-dependent changes in splanchnic hemodynamics and systemic blood pressure in healthy subjects.
    Gasic S; Eichler HG; Korn A
    J Cardiovasc Pharmacol; 1985; 7(2):219-23. PubMed ID: 2581071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of blood pressure elevation during angiotensin infusion.
    Stokland O; Thorvaldson J; Ilebekk A; Kiil F
    Acta Physiol Scand; 1982 Aug; 115(4):455-65. PubMed ID: 7180536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man.
    Fagard R; Cattaert A; Lijnen P; Staessen J; Vanhees L; Moerman E; Amery A
    Clin Sci (Lond); 1984 Jan; 66(1):17-25. PubMed ID: 6690191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cardiovascular and hemodynamic effects of derivatives of metoclopramide].
    Mouillé P; Cheymol G
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):139-49. PubMed ID: 1156043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin.
    Verheyen A; Vlaminckx E; Lauwers F; Van Den Broeck C; Wouters L
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):280-98. PubMed ID: 6486974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery.
    Richter JA; Barankay A; Göb E; Späth P
    J Cardiovasc Pharmacol; 1986; 8(1):109-15. PubMed ID: 2419672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of anesthesia and phenoxybenzamine on responses of dogs to IV subtoxic doses of 3,4-methylenedioxyamphetamine (MDA).
    Waters IW; Catravas JD; Davis WM
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):240-51. PubMed ID: 3753103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent.
    Persson B; Hedner T; Henning M
    J Pharm Pharmacol; 1982 Jul; 34(7):442-5. PubMed ID: 6126541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ketanserin on central haemodynamics and coronary circulation.
    Hood S; Birnie D; Nasser A; Hillis WS
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):983-7. PubMed ID: 9869505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plethysmographic registration of volume changes in a hand vein. Effects of serotonin and of a specific antagonist.
    Jageneau AH; Hörig C; Loots W; Symoens J
    Angiology; 1980 Dec; 31(12):828-32. PubMed ID: 7469121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep.
    Nelson M; Coghlan JP; Denton DA; Tresham JJ; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):555-63. PubMed ID: 3124998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.